Trial Information
A Phase I Study of Tomotherapy in Patients With Benign Brain Tumour
Inclusion Criteria:
- Histopathologically confirmed newly diagnosed base of skull benign tumour
- Karnofsky Performance Status (KPS) equal to or greater than 70
Exclusion Criteria:
- Brain metastases or recurrent tumour
- Prior radiotherapy (RT) to head or neck
- No prior chemotherapy or radiosensitizer
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
safety and adverse effects
Outcome Time Frame:
Trial Completion
Safety Issue:
Yes
Principal Investigator
Wilson Roa, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Alberta Health Services
Authority:
Canada: Health Canada
Study ID:
CNS-09-0029 / ethics 21879
NCT ID:
NCT00128986
Start Date:
May 2005
Completion Date:
July 2012
Related Keywords:
- Brain Neoplasms
- radiotherapy
- brain
- Brain Neoplasms
- Neoplasms